General Pharmaceutical Council determination — review hearing
GPhC found Habib Noman Iqbal no longer impaired at November 2024 review
The committee recognised insight and remediation, finding a low risk of repetition. It concluded that Mr Iqbal could return to practice when his existing suspension expired.
MedicWatch editorial · Published 29 November 2024 · Updated 22 September 2026
No impairment found
Data last checked: 22 September 2026Report a correction
What does “no impairment found” mean?
The regulator found no current impairment in this decision. Read the decision for its effect on any existing order and check the official register for the practitioner's current status.
Concerning Habib Noman Iqbal, pharmacist (General Pharmaceutical Council 2212445).
Decision date: 29 November 2024 · Hearing started 29 November 2024
In plain English
The GPhC committee found that Habib Noman Iqbal's fitness to practise was no longer impaired at a review on 29 November 2024. It recognised developed insight, targeted training and acceptance of responsibility for earlier waste-handling failings and dishonesty. It found the risk of repetition low and concluded that he could return to practice when his existing three-month suspension expired.
Charges
This review concerned a three-month suspension imposed in August 2024 following failings in storing and disposing of confidential waste, medicines and syringes, and a dishonest report about when Mr Iqbal learned of the incident. It did not determine new allegations.
Findings
The committee found that fitness to practise was no longer impaired. It accepted that Mr Iqbal had fully accepted responsibility, developed insight, completed targeted training and remediated his wrongdoing, leaving a low risk of repetition. It concluded that the suspension had met the public interest and that he could return to practice when the existing order expired.
Source
All facts on this page are drawn from the publicly published General Pharmaceutical Council determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.